nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—melanoma—vitiligo	0.456	0.518	CtDrD
Vemurafenib—skin cancer—vitiligo	0.424	0.482	CtDrD
Vemurafenib—CYP1A2—Methoxsalen—vitiligo	0.0695	0.656	CbGbCtD
Vemurafenib—CYP3A4—Methoxsalen—vitiligo	0.0364	0.344	CbGbCtD
Vemurafenib—Sunburn—Methoxsalen—vitiligo	0.00305	0.323	CcSEcCtD
Vemurafenib—Folliculitis—Methoxsalen—vitiligo	0.00146	0.155	CcSEcCtD
Vemurafenib—RAF1—hair follicle—vitiligo	0.000916	0.262	CbGeAlD
Vemurafenib—RAF1—neck—vitiligo	0.000614	0.176	CbGeAlD
Vemurafenib—Dry skin—Methoxsalen—vitiligo	0.000613	0.0648	CcSEcCtD
Vemurafenib—Photosensitivity reaction—Methoxsalen—vitiligo	0.000527	0.0558	CcSEcCtD
Vemurafenib—ABCC1—hair follicle—vitiligo	0.000458	0.131	CbGeAlD
Vemurafenib—BRAF—thyroid gland—vitiligo	0.000439	0.125	CbGeAlD
Vemurafenib—Erythema—Methoxsalen—vitiligo	0.000402	0.0426	CcSEcCtD
Vemurafenib—RAF1—skin of body—vitiligo	0.000398	0.114	CbGeAlD
Vemurafenib—Dysgeusia—Methoxsalen—vitiligo	0.000394	0.0417	CcSEcCtD
Vemurafenib—Infection—Methoxsalen—vitiligo	0.000326	0.0345	CcSEcCtD
Vemurafenib—Skin disorder—Methoxsalen—vitiligo	0.000319	0.0338	CcSEcCtD
Vemurafenib—Hypotension—Methoxsalen—vitiligo	0.000307	0.0325	CcSEcCtD
Vemurafenib—RAF1—thyroid gland—vitiligo	0.000292	0.0836	CbGeAlD
Vemurafenib—Gastrointestinal disorder—Methoxsalen—vitiligo	0.000284	0.03	CcSEcCtD
Vemurafenib—Body temperature increased—Methoxsalen—vitiligo	0.00026	0.0275	CcSEcCtD
Vemurafenib—Hypersensitivity—Methoxsalen—vitiligo	0.000242	0.0256	CcSEcCtD
Vemurafenib—Pruritus—Methoxsalen—vitiligo	0.000232	0.0246	CcSEcCtD
Vemurafenib—Dizziness—Methoxsalen—vitiligo	0.000217	0.023	CcSEcCtD
Vemurafenib—Rash—Methoxsalen—vitiligo	0.000207	0.0219	CcSEcCtD
Vemurafenib—Dermatitis—Methoxsalen—vitiligo	0.000207	0.0219	CcSEcCtD
Vemurafenib—Headache—Methoxsalen—vitiligo	0.000206	0.0218	CcSEcCtD
Vemurafenib—BRAF—PDGFR-beta signaling pathway—SLA—vitiligo	0.000196	0.0975	CbGpPWpGaD
Vemurafenib—Nausea—Methoxsalen—vitiligo	0.000195	0.0206	CcSEcCtD
Vemurafenib—ABCC1—thyroid gland—vitiligo	0.000146	0.0418	CbGeAlD
Vemurafenib—RAF1—PDGFR-beta signaling pathway—SLA—vitiligo	0.000136	0.0675	CbGpPWpGaD
Vemurafenib—ABCG2—thyroid gland—vitiligo	0.000121	0.0346	CbGeAlD
Vemurafenib—CYP1A2—thyroid gland—vitiligo	0.000116	0.0333	CbGeAlD
Vemurafenib—BRAF—Downstream signaling in naïve CD8+ T cells—GZMB—vitiligo	6.15e-05	0.0306	CbGpPWpGaD
Vemurafenib—CYP1A2—Aflatoxin B1 metabolism—GSTM1—vitiligo	6.03e-05	0.03	CbGpPWpGaD
Vemurafenib—RAF1—Signaling events mediated by Stem cell factor receptor (c-Kit)—MITF—vitiligo	5.9e-05	0.0294	CbGpPWpGaD
Vemurafenib—RAF1—TWEAK Signaling Pathway—CASP7—vitiligo	5.59e-05	0.0278	CbGpPWpGaD
Vemurafenib—RAF1—Signaling events mediated by Stem cell factor receptor (c-Kit)—SH2B3—vitiligo	5.26e-05	0.0262	CbGpPWpGaD
Vemurafenib—RAF1—Kit receptor signaling pathway—MITF—vitiligo	5.26e-05	0.0261	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of retinoblastoma protein—MITF—vitiligo	4.8e-05	0.0239	CbGpPWpGaD
Vemurafenib—CYP3A4—Aflatoxin B1 metabolism—GSTM1—vitiligo	4.66e-05	0.0232	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling in naïve CD8+ T cells—GZMB—vitiligo	4.26e-05	0.0212	CbGpPWpGaD
Vemurafenib—RAF1—Oncostatin M Signaling Pathway—CASP7—vitiligo	3.94e-05	0.0196	CbGpPWpGaD
Vemurafenib—BRAF—Downstream signaling in naïve CD8+ T cells—CD8A—vitiligo	3.8e-05	0.0189	CbGpPWpGaD
Vemurafenib—BRAF—Senescence and Autophagy in Cancer—CD44—vitiligo	3.46e-05	0.0172	CbGpPWpGaD
Vemurafenib—BRAF—Downstream signaling in naïve CD8+ T cells—IL2RA—vitiligo	3.43e-05	0.0171	CbGpPWpGaD
Vemurafenib—RAF1—IL-2 Signaling Pathway—IL2RA—vitiligo	3.41e-05	0.0169	CbGpPWpGaD
Vemurafenib—RAF1—TCR Signaling Pathway—SH2B3—vitiligo	3.34e-05	0.0166	CbGpPWpGaD
Vemurafenib—RAF1—Interleukin-2 signaling—IL2RA—vitiligo	3.11e-05	0.0155	CbGpPWpGaD
Vemurafenib—RAF1—TNF alpha Signaling Pathway—CASP7—vitiligo	2.99e-05	0.0149	CbGpPWpGaD
Vemurafenib—CYP1A2—Estrogen metabolism—GSTM1—vitiligo	2.83e-05	0.0141	CbGpPWpGaD
Vemurafenib—RAF1—IL2-mediated signaling events—IL2RA—vitiligo	2.79e-05	0.0139	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—CASP7—vitiligo	2.67e-05	0.0133	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling in naïve CD8+ T cells—CD8A—vitiligo	2.63e-05	0.0131	CbGpPWpGaD
Vemurafenib—RAF1—SHP2 signaling—IL2RA—vitiligo	2.63e-05	0.0131	CbGpPWpGaD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—CD44—vitiligo	2.4e-05	0.0119	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling in naïve CD8+ T cells—IL2RA—vitiligo	2.37e-05	0.0118	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—SH2B3—vitiligo	2.33e-05	0.0116	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—LRR1—vitiligo	2.2e-05	0.0109	CbGpPWpGaD
Vemurafenib—CYP3A4—Estrogen metabolism—GSTM1—vitiligo	2.19e-05	0.0109	CbGpPWpGaD
Vemurafenib—RAF1—TCR Signaling Pathway—CD8A—vitiligo	2.05e-05	0.0102	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—CASP7—vitiligo	1.85e-05	0.00918	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—NLRP1—vitiligo	1.83e-05	0.00911	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—HERC2—vitiligo	1.67e-05	0.00829	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—CASP7—vitiligo	1.67e-05	0.00829	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Interleukins—IL2RA—vitiligo	1.6e-05	0.00796	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—CAT—vitiligo	1.52e-05	0.00755	CbGpPWpGaD
Vemurafenib—CYP1A2—Tryptophan metabolism—CAT—vitiligo	1.42e-05	0.00705	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR—CD80—vitiligo	1.4e-05	0.00694	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—LRR1—vitiligo	1.33e-05	0.00664	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR in disease—CD80—vitiligo	1.3e-05	0.00647	CbGpPWpGaD
Vemurafenib—CYP1A2—Phase II conjugation—GSTT1—vitiligo	1.25e-05	0.00622	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—CAT—vitiligo	1.21e-05	0.006	CbGpPWpGaD
Vemurafenib—BRAF—NGF signalling via TRKA from the plasma membrane—CD80—vitiligo	1.15e-05	0.00573	CbGpPWpGaD
Vemurafenib—CYP3A4—Tryptophan metabolism—CAT—vitiligo	1.09e-05	0.00544	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—CD44—vitiligo	1.09e-05	0.00544	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—CD80—vitiligo	1.08e-05	0.00537	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—NLRP1—vitiligo	1.07e-05	0.00531	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—CD80—vitiligo	1.03e-05	0.00514	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—CD80—vitiligo	1.02e-05	0.00505	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HERC2—vitiligo	1.01e-05	0.00503	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—CD80—vitiligo	9.7e-06	0.00483	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—CD80—vitiligo	9.66e-06	0.0048	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—CD80—vitiligo	9.61e-06	0.00478	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—CD80—vitiligo	9.56e-06	0.00476	CbGpPWpGaD
Vemurafenib—RAF1—Platelet activation, signaling and aggregation—IL2RA—vitiligo	9.02e-06	0.00449	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—CD80—vitiligo	9e-06	0.00448	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—CD80—vitiligo	9e-06	0.00448	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—CD80—vitiligo	9e-06	0.00448	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—CD80—vitiligo	8.91e-06	0.00444	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—CD80—vitiligo	8.86e-06	0.00441	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—CD80—vitiligo	8.84e-06	0.0044	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—CD80—vitiligo	8.8e-06	0.00438	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—GSTT1—vitiligo	8.63e-06	0.00429	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—SH2B3—vitiligo	8.39e-06	0.00418	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CCR6—vitiligo	7.97e-06	0.00397	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—IFIH1—vitiligo	7.97e-06	0.00397	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—CD80—vitiligo	7.97e-06	0.00396	CbGpPWpGaD
Vemurafenib—CYP1A2—Phase II conjugation—GSTM1—vitiligo	7.96e-06	0.00396	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—IL2RA—vitiligo	7.47e-06	0.00372	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—GSTT1—vitiligo	7.31e-06	0.00364	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—CD44—vitiligo	6.81e-06	0.00339	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—MC1R—vitiligo	6.8e-06	0.00338	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—CD80—vitiligo	6.13e-06	0.00305	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MC1R—vitiligo	5.81e-06	0.00289	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CTLA4—vitiligo	5.8e-06	0.00289	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—GSTT1—vitiligo	5.64e-06	0.00281	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—GSTM1—vitiligo	5.5e-06	0.00274	CbGpPWpGaD
Vemurafenib—CYP2D6—Metapathway biotransformation—GSTM1—vitiligo	5.42e-06	0.0027	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CCR6—vitiligo	5.08e-06	0.00253	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—IL2RA—vitiligo	4.86e-06	0.00242	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CD44—vitiligo	4.76e-06	0.00237	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—GSTM1—vitiligo	4.66e-06	0.00232	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—IL2RA—vitiligo	4.65e-06	0.00231	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IFIH1—vitiligo	4.64e-06	0.00231	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CCR6—vitiligo	4.64e-06	0.00231	CbGpPWpGaD
Vemurafenib—CYP1A2—Metapathway biotransformation—GSTM1—vitiligo	4.59e-06	0.00229	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—SH2B3—vitiligo	4.52e-06	0.00225	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD8A—vitiligo	4.46e-06	0.00222	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CCR6—vitiligo	4.34e-06	0.00216	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—SH2B3—vitiligo	4.11e-06	0.00205	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—GZMB—vitiligo	4.09e-06	0.00203	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MC1R—vitiligo	4.02e-06	0.002	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—CD44—vitiligo	3.66e-06	0.00182	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—GSTM1—vitiligo	3.59e-06	0.00179	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD44—vitiligo	3.57e-06	0.00178	CbGpPWpGaD
Vemurafenib—CYP3A4—Metapathway biotransformation—GSTM1—vitiligo	3.55e-06	0.00176	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CTLA4—vitiligo	3.52e-06	0.00175	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CD80—vitiligo	3.5e-06	0.00174	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD80—vitiligo	3.36e-06	0.00167	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CD44—vitiligo	3.3e-06	0.00164	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GSTT1—vitiligo	3.29e-06	0.00164	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CD44—vitiligo	3.27e-06	0.00163	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCR6—vitiligo	3e-06	0.00149	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GSTT1—vitiligo	2.9e-06	0.00144	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SH2B3—vitiligo	2.85e-06	0.00142	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—GZMB—vitiligo	2.83e-06	0.00141	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CD44—vitiligo	2.74e-06	0.00136	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CD80—vitiligo	2.72e-06	0.00135	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD8A—vitiligo	2.71e-06	0.00135	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL2RA—vitiligo	2.67e-06	0.00133	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—IL2RA—vitiligo	2.5e-06	0.00125	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL2RA—vitiligo	2.44e-06	0.00121	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CD44—vitiligo	2.41e-06	0.0012	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL2RA—vitiligo	2.28e-06	0.00113	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CAT—vitiligo	2.22e-06	0.0011	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GSTM1—vitiligo	2.1e-06	0.00104	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD80—vitiligo	2.04e-06	0.00101	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CAT—vitiligo	1.95e-06	0.000972	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CD80—vitiligo	1.9e-06	0.000946	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CD80—vitiligo	1.88e-06	0.000935	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CD80—vitiligo	1.86e-06	0.000927	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GSTM1—vitiligo	1.85e-06	0.000918	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GSTT1—vitiligo	1.79e-06	0.000889	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL2RA—vitiligo	1.58e-06	0.000785	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CD44—vitiligo	1.49e-06	0.000739	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GSTT1—vitiligo	1.48e-06	0.000734	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CD80—vitiligo	1.32e-06	0.000655	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GSTT1—vitiligo	1.25e-06	0.000622	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CD44—vitiligo	1.23e-06	0.00061	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CAT—vitiligo	1.21e-06	0.0006	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GSTM1—vitiligo	1.14e-06	0.000567	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CD44—vitiligo	1.04e-06	0.000517	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CAT—vitiligo	9.96e-07	0.000495	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GSTT1—vitiligo	9.65e-07	0.00048	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GSTM1—vitiligo	9.4e-07	0.000468	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CAT—vitiligo	8.43e-07	0.00042	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CD44—vitiligo	8.02e-07	0.000399	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GSTM1—vitiligo	7.97e-07	0.000396	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CAT—vitiligo	6.51e-07	0.000324	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GSTM1—vitiligo	6.15e-07	0.000306	CbGpPWpGaD
